Cantor Fitzgerald Reaffirms “Overweight” Rating for Arcturus Therapeutics (NASDAQ:ARCT)
Cantor Fitzgerald restated their overweight rating on shares of Arcturus Therapeutics (NASDAQ:ARCT – Free Report) in a research report report published on Monday morning,Benzinga reports. Separately, HC Wainwright restated a “buy” rating and set a $63.00 price target on shares of Arcturus Therapeutics in a research report on Friday, November 8th. Six investment analysts have […]
More Stories
Stellantis (OTCMKTS:PUGOY) Stock Price Crosses Below 200-Day Moving Average – Here’s What Happened
Shares of Stellantis (OTCMKTS:PUGOY – Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The...
Exelixis (NASDAQ:EXEL) Lowered to Neutral Rating by Bank of America
Exelixis (NASDAQ:EXEL – Get Free Report) was downgraded by equities research analysts at Bank of America from a “buy” rating...
Quest Resource (NASDAQ:QRHC) Stock Price Crosses Below 200-Day Moving Average – Here’s What Happened
Shares of Quest Resource Holding Co. (NASDAQ:QRHC – Get Free Report) passed below its two hundred day moving average during...
BBGI Global Infrastructure (LON:BBGI) Share Price Crosses Below 200 Day Moving Average – Time to Sell?
BBGI Global Infrastructure (LON:BBGI – Get Free Report)’s share price crossed below its 200-day moving average during trading on Wednesday...
Synovus Financial Corp Makes New Investment in Vanguard Russell 1000 Value (NASDAQ:VONV)
Synovus Financial Corp purchased a new stake in Vanguard Russell 1000 Value (NASDAQ:VONV – Free Report) in the third quarter,...
Synovus Financial Corp Sells 4,122 Shares of WNS (Holdings) Limited (NYSE:WNS)
Synovus Financial Corp decreased its position in WNS (Holdings) Limited (NYSE:WNS – Free Report) by 37.0% during the 3rd quarter,...